Edition:
United States

Oriola Oyj (OKDBV.HE)

OKDBV.HE on Helsinki Stock Exchange

3.00EUR
22 May 2018
Change (% chg)

€-0.00 (-0.17%)
Prev Close
€3.01
Open
€3.01
Day's High
€3.03
Day's Low
€2.97
Volume
60,860
Avg. Vol
217,263
52-wk High
€3.81
52-wk Low
€2.40

Chart for

About

Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments... (more)

Overall

Beta: 0.13
Market Cap(Mil.): €540.45
Shares Outstanding(Mil.): 181.49
Dividend: 0.09
Yield (%): 3.00

Financials

  OKDBV.HE Industry Sector
P/E (TTM): 24.77 23.65 38.77
EPS (TTM): 0.12 -- --
ROI: 7.79 11.56 46.42
ROE: 12.19 13.33 54.22

BRIEF-Oriola Oyj - Oriola Corporation Invests In Swedish Online Medical Center Doktor.SE

* ORIOLA CORPORATION INVESTS IN SWEDISH ONLINE MEDICAL CENTER DOKTOR.SE

May 04 2018

BRIEF-Oriola Q1 Operating Profit Below Expectations At EUR 5.6 Million

* Q1 NET SALES EUR 388.1 MILLION (REUTERS POLL EUR 372 MILLION)

Apr 27 2018

BRIEF-Oriola appoints ‍Helena Kukkonen new CFO

* ‍HELENA KUKKONEN HAS BEEN APPOINTED ORIOLA CORPORATION'S CHIEF FINANCIAL OFFICER (CFO) AS OF MARCH 12, 2018​

Feb 13 2018

BRIEF-Oriola Nominates Robert W. Andersson New President And CEO

* SAYS ‍ORIOLA CORPORATION'S BOARD OF DIRECTORS HAS DECIDED TO NOMINATE ROBERT W. ANDERSSON AS COMPANY'S NEW PRESIDENT AND CEO EFFECTIVE LATEST MARCH 1, 2018​

Dec 18 2017

BRIEF-Oriola Specifies Outlook For 2017

* - ‍UPDATED OUTLOOK: 2017 ADJUSTED EBIT FROM CONTINUING OPERATIONS ON CONSTANT CURRENCY BASIS IS ESTIMATED TO BE EUR 39 - 42 MILLION​

Dec 18 2017

Earnings vs. Estimates